Common Contracts

EX-10.321 2 dex10321.htm EXCLUSIVE PATENT LICENSE AGREEMENT CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE...

Exclusive Patent License Agreement • May 5th, 2020 • California

• Contract Type
  Exclusive Patent License Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  California

This EXCLUSIVE PATENT LICENSE AGREEMENT (the “Agreement”), effective as of this 18th day of June, 2009 (the “Effective Date”), is entered into by and between Glycomed, Inc., a California corporation and a wholly owned subsidiary of Ligand Pharmaceuticals Incorporated (“Glycomed”), and ParinGenix, Inc., a Delaware corporation (“ParinGenix”).

EXCLUSIVE PATENT LICENSE AGREEMENT

Exclusive Patent License Agreement • August 4th, 2009 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California

• Contract Type
  Exclusive Patent License Agreement
• Filed
  August 4th, 2009
• Company
  Ligand Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

This EXCLUSIVE PATENT LICENSE AGREEMENT (the “Agreement”), effective as of this 18th day of June, 2009 (the “Effective Date”), is entered into by and between Glycomed, Inc., a California corporation and a wholly owned subsidiary of Ligand Pharmaceuticals Incorporated (“Glycomed”), and ParinGenix, Inc., a Delaware corporation (“ParinGenix”).